Elepsia XR Approval History
- FDA approved: Yes (First approved March 2nd, 2015)
- Brand name: Elepsia XR
- Generic name: levetiracetam
- Dosage form: Extended-Release Tablets
- Company: Sun Pharmaceutical Industries Inc.
- Treatment for: Epilepsy
Elepsia XR (levetiracetam) is an extended-release formulation of the antiepileptic drug levetiracetam designed to reduce pill burden in patients receiving high doses for the treatment of partial onset seizures.
Development History and FDA Approval Process for Elepsia XR
|Mar 4, 2015||SPARC Announces FDA Approval of Elepsia XR (levetiracetam) Extended-Release Tablets|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.